After graduating, Wojcicki worked as a healthcare consultant at Passport Capital, a San Francisco-based investment fund[6] and Investor AB.[5] She was a healthcare investment analyst[7] for four years, overseeing health care investments and focusing on biotechnology companies. Disillusioned by the culture of Wall Street and its attitude towards health care,[10] she decided to forgo taking the MCAT to enroll in medical school and instead decided to focus on biological research.[5]
Wojcicki is a member of the Xconomists, an ad hoc team of editorial advisors for the tech news and media company Xconomy.[11] In October 2013, Fast Company named Wojcicki "The Most Daring CEO".[5][12] She is a co-founder and board member of the Breakthrough Prize.[13] As of 2020, she is listed as number 93 in Forbes list of the World's 100 Most Powerful Women.[14] In August 2021 Wojcicki joined the board of Cazoo.[15]
Wojcicki has been closely involved in the downtown business district of Los Altos, California. In approximately 2005, Wojcicki and her then husband Sergey Brin bought at least half a dozen commercial properties in downtown Los Altos.[16] Under the name of Passerelle Investment Company, they sponsored events and urban planning initiatives throughout the downtown business district. In 2016, the firm was renamed to Los Altos Community Investments and given a tighter focus on commercial real-estate development. In 2021, Los Altos Community Investments opened a food hall in downtown Los Altos called the State Street Market.[17]
23andMe
Wojcicki co-founded and is CEO of 23andMe, a direct-to-consumer DNA testing company that allows consumers to test for ancestry and health risks.[7][18] She founded the company in 2006, with Linda Avey and Paul Cusenza, intending to provide common people access to their genetic information, which could further provide information on cures for diseases or treatments , especially with the help of GSK plc and their $300 million investment.[18][19] Wojcicki has expressed interest in "revolutioniz[ing] health care" with DNA testing,[18] as it could provide consumers with enough information to predict potential genetic illnesses.
Consumers can purchase testing kits that provide information on ancestry, health, and genetic traits. The company takes saliva samples that are mailed in by buyers, and processes the genetic data, posting the results online for the buyer to view.[20]
When Wojcicki took 23andMe public through a merger with a special-purpose acquisition company in 2021, Forbes dubbed her the "newest self-made billionaire."[25] By 2024, the company's valuation had fallen to 2 percent of its peak value of $6 billion,[26] prompting Wojcicki to make a buyout offer to take the company private; the company's board of directors rejected her proposal and all seven independent directors quit.[27][28]
^ abcdHafner, Katie (May 29, 2007). "Silicon Valley Wide-Eyed Over a Bride". The New York Times. Archived from the original on September 18, 2012. Retrieved July 2, 2013. Anne Wojcicki, the 33-year-old former health care investment analyst who this month married a handsome young computer scientist..
^23andMe. "board members". Archived from the original on October 23, 2012. Retrieved October 17, 2012.{{cite web}}: CS1 maint: numeric names: authors list (link)
^Hamilton, Anita (October 29, 2008). "Best Inventions of 2008". Content Time. Archived from the original on March 13, 2012. Retrieved January 25, 2014.
^Zalewski, Wojciech (October 1, 2011). "Janina Wójcicka Hoskins (1912–1996): Portrait of an Esteemed Librarian". Slavic & East European Information Resources. 12 (4): 224–236. doi:10.1080/15228886.2011.623117. ISSN1522-8886. S2CID144135260.